HIGHLAND CAPITAL MANAGEMENT LP - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 83 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q1 2019. The put-call ratio across all filers is 1.57 and the average weighting 0.9%.

Quarter-by-quarter ownership
HIGHLAND CAPITAL MANAGEMENT LP ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q2 2019$635,000
+43.7%
68,7000.0%0.04%
+32.1%
Q1 2019$442,000
-71.7%
68,700
-58.5%
0.03%
-76.7%
Q4 2018$1,563,000
+100.6%
165,700
+328.2%
0.12%
+179.1%
Q3 2018$779,000
-31.0%
38,7000.0%0.04%
-32.8%
Q2 2018$1,129,000
+48.7%
38,700
+51.8%
0.06%
+64.1%
Q1 2018$759,000
-65.4%
25,500
-65.3%
0.04%
-65.2%
Q1 2017$2,194,00073,5000.11%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q1 2019
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,018,00094.79%
TANG CAPITAL MANAGEMENT LLC 9,405,490$39,879,00011.22%
RTW INVESTMENTS, LP 2,327,903$9,870,0000.15%
Boxer Capital, LLC 890,700$3,777,0000.13%
FIRST MIDWEST BANK TRUST DIVISION 89,341$379,0000.05%
WealthTrust Axiom LLC 30,400$128,0000.04%
PREMIER ASSET MANAGEMENT LLC 51,305$217,0000.04%
OCCUDO QUANTITATIVE STRATEGIES LP 18,113$77,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 39,000$165,0000.02%
Inscription Capital, LLC 10,000$42,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders